Tag Archives: Federal Trade Commission

US v. Caronia: What Constitutes 'Truthful' Speech?

By Ben Comer | Published: December 5, 2012

If a drug’s label is not the final word on what is true – or untrue – about a product, then who decides what can and cannot be said during a sales detail?

Posted in Advertising, FDA, Legal, Marketing, Regulatory, Safety, Sales, Strategy, compliance | Also tagged Alfred Caronia, Appeals Court, Detailing, DoJ, FDA, FTC, Jazz Pharmaceuticals, Marketing, off-label, Office of Prescription Drug Promotion, Orphan Medical, OTC, Professional Marketing, Promotion, Regulatory, sales rep, Sorrell v. IMS Health, US v. Caronia | 1 Comment